| Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial B O'Sullivan, AM Davis, R Turcotte, R Bell, C Catton, P Chabot, J Wunder, ... The Lancet 359 (9325), 2235-2241, 2002 | 1733 | 2002 |
| Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. KE Noonan, C Beck, TA Holzmayer, JE Chin, JS Wunder, IL Andrulis, ... Proceedings of the National Academy of Sciences 87 (18), 7160-7164, 1990 | 1058 | 1990 |
| Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma AM Davis, B O'Sullivan, R Turcotte, R Bell, C Catton, P Chabot, J Wunder, ... Radiotherapy and oncology 75 (1), 48-53, 2005 | 707 | 2005 |
| Detectable clonal mosaicism and its relationship to aging and cancer KB Jacobs, M Yeager, W Zhou, S Wacholder, Z Wang, ... Nature genetics 44 (6), 651-658, 2012 | 664 | 2012 |
| EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. E De Alava, A Kawai, JH Healey, I Fligman, PA Meyers, AG Huvos, ... Journal of Clinical Oncology 16 (4), 1248-1255, 1998 | 586 | 1998 |
| Treatment of giant-cell tumors of long bones with curettage and bone-grafting HR Blackley, JS Wunder, AM Davis, LM White, R Kandel, RS Bell JBJS 81 (6), 811-20, 1999 | 507 | 1999 |
| Giant cell tumor of long bone: a Canadian Sarcoma Group study RE Turcotte, JS Wunder, MH Isler, RS Bell, N Schachar, BA Masri, ... Clinical Orthopaedics and Related Research® 397, 248-258, 2002 | 499 | 2002 |
| Chordoma: long-term follow-up after radical photon irradiation C Catton, B O'Sullivan, R Bell, N Laperriere, B Cummings, V Fornasier, ... Radiotherapy and Oncology 41 (1), 67-72, 1996 | 442 | 1996 |
| Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft … D Callegaro, R Miceli, S Bonvalot, P Ferguson, DC Strauss, A Levy, ... The Lancet Oncology 17 (5), 671-680, 2016 | 392 | 2016 |
| Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor) S Tejpar, F Nollet, C Li, JS Wunder, G Michils, P dal Cin, E Van Cutsem, ... Oncogene 18 (47), 6615-6620, 1999 | 388 | 1999 |
| Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape C Lu, SU Jain, D Hoelper, D Bechet, RC Molden, L Ran, D Murphy, ... Science 352 (6287), 844-849, 2016 | 380 | 2016 |
| Residual disease following unplanned excision of a soft-tissue sarcoma of an extremity S Noria, A Davis, R Kandel, J Levesque, B O'SULLIVAN, JAY Wunder, ... JBJS 78 (5), 650, 1996 | 342 | 1996 |
| Side population cells isolated from mesenchymal neoplasms have tumor initiating potential C Wu, Q Wei, V Utomo, P Nadesan, H Whetstone, R Kandel, JS Wunder, ... Cancer research 67 (17), 8216-8222, 2007 | 311 | 2007 |
| Cartilage tumours and bone development: molecular pathology and possible therapeutic targets JVMG Bovée, PCW Hogendoorn, JS Wunder, BA Alman Nature Reviews Cancer 10 (7), 481-488, 2010 | 302 | 2010 |
| Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma AM Davis, B O’sullivan, RS Bell, R Turcotte, CN Catton, JS Wunder, ... Journal of clinical oncology 20 (22), 4472-4477, 2002 | 301 | 2002 |
| The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma JS Wunder, G Paulian, AG Huvos, G Heller, PA MEYERS, JH HEALEY JBJS 80 (7), 1020-33, 1998 | 283 | 1998 |
| Phase 2 study of preoperative image‐guided intensity‐modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma B O'Sullivan, AM Griffin, CI Dickie, MB Sharpe, PWM Chung, CN Catton, ... Cancer 119 (10), 1878-1884, 2013 | 257 | 2013 |
| Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: a matched case-control study AM Davis, M Devlin, AM Griffin, JS Wunder, RS Bell Archives of physical medicine and rehabilitation 80 (6), 615-618, 1999 | 227 | 1999 |
| Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone P Rutkowski, S Ferrari, RJ Grimer, PD Stalley, SPD Dijkstra, A Pienkowski, ... Annals of surgical oncology 22, 2860-2868, 2015 | 206 | 2015 |
| Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis WY Chen, TK Cooper, CA Zahnow, M Overholtzer, Z Zhao, M Ladanyi, ... Cancer Cell 6 (4), 387-398, 2004 | 206 | 2004 |
